Antifungal Resistance in Pathogenic Fungi
Top Cited Papers
Open Access
- 1 November 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (9) , 1073-1080
- https://doi.org/10.1086/344058
Abstract
Pathogenic fungi are the cause of life-threatening infections in an increasing number of immunocompromised patients. The intrinsic resistance to antiKeywords
This publication has 70 references indexed in Scilit:
- Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998Antimicrobial Agents and Chemotherapy, 2000
- Antifungal prophylaxis during neutropenia and immunodeficiencyClinical Microbiology Reviews, 1997
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- Epidemiology of nosocomial fungal infectionsClinical Microbiology Reviews, 1996
- Nosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of TransmissionClinical Infectious Diseases, 1996
- Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformansClinical Microbiology Reviews, 1995
- Importance of Candida Species Other than C. albicans as Pathogens in Oncology PatientsClinical Infectious Diseases, 1995
- Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistanceThe American Journal of Medicine, 1994
- Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patientsAntimicrobial Agents and Chemotherapy, 1993
- Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with FluconazoleNew England Journal of Medicine, 1991